Why.
To play a key role in developing scientific research to improve diagnosis, treatment and medical understanding of ME/CFS and other neuroimmune diseases.
To help fund and conduct pilot studies to determine diagnostic markers and potential treatments for ME/CFS.
To openly share our findings with the scientific and medical communities to help develop translational science that ultimately improves the quality of life for people suffering from ME/CFS.
Simmaron Research’s pioneering scientific work is led by ME/CFS expert Dr. Daniel Peterson and Fellow Dr. Gunnar Gottschalk and carried out by a team of dedicated professionals. The SRI team’s ability to carry out this visionary work remains dependent on funding predominantly received through acts of philanthropy and generosity by people who care about our mission. In addition to always keeping our efforts mission-focused, our team is also distinctly dedicated to the following areas of excellence:
Our legacy of excellence in research
The Simmaron difference
Pilot Studies
Neither the government nor private industry will fund large studies without first having evidence from smaller studies – pre-pilot and pilot investigations – demonstrating that a particular avenue of research is valid and worth pursuing. The lack of those smaller studies is a significant deficit in ME/CFS research. That’s why the Simmaron team has spent several years generating novel studies that have and continue to inform the pursuit of larger ones.
Clinical Ingenuity, Diagnostics, & Treatment
Strategically positioned in the field of translational science, the Simmaron team works closely with our clinical partner, Sierra Internal Medicine, to conduct studies that look more closely at biomarkers for disease, efficacy of applied therapies, and comparative outcomes in patient cohorts.
Data Wealth
Thanks to our clinical partner and others, the Simmaron team has access to nearly three decades of biological samples and records from approximately 1,000 ME/CFS patients. We store this data, manage it with integrity, and use it in research. While we have tapped into this data wealth over several years of work, there remain countless ways to study what we possess in our freezers and files.
Collaborative Relationship Building
As recognition of the need for study in ME/CFS and other neuroimmune disorders grows, so does Simmaron’s network of collaborators. Our foundation’s scientific advisory board, study partners, and sponsored scientists span the globe. Drawing on the rich insights from our network, we conduct collaborative work that is both groundbreaking and necessary for changing the clinical landscape.
Legacy Training
The Simmaron team takes every opportunity to pass on knowledge and skills to young people brought into our workspace through our internship and fellowship programs. We are committed to elevating the way the next generation of medical professionals understands ME/CFS.
Simmaron Research Inc. is a 501c3 non-profit organization based in Incline Village, Nevada. Our work advances translational science in treating neuroimmune diseases like ME/CFS. Translational science is the combination of research findings and clinical experience. The application of translational science makes possible enhanced clinician techniques and ultimately improves the quality of life for people suffering from ME/CFS and related neuroimmune disorders.